Work Schedule
Standard (Mon-Fri)Environmental Conditions
Laboratory Setting, OfficeJob Description
Location/Division Specific Information:
Olink, part of Thermo Fisher Scientific, is dedicated to advancing the understanding of human disease through proteomics. Olink panels provide innovative, high-quality solutions for human protein biomarker discovery, enabling researchers to measure thousands of proteins simultaneously from just a few microliters of blood. Using highly specific and thoroughly validated assays with a wide dynamic range, Olink’s technology overcomes traditional limitations in protein analysis and supports deeper insights into human biology and disease.
Job Description
The Innovation Centre drives the next generation of technologies, products, and applications for protein biomarker discovery. As a Scientist in the Innovation Centre, you will play a key experimental role in advancing Olink’s platforms, with a strong focus on molecular biology, immune assay development, quantitative PCR (qPCR), and next generation sequencing (NGS).
This is a highly laboratory-based position. You will design and execute experiments, develop and optimize sequencing- and qPCR-based immunoassays, and contribute to the advancement of molecular workflows that underpin Olink technologies. You will collaborate closely with senior scientists, bioinformaticians, and project managers to translate innovative concepts into robust, scalable assays.
A Day in the Life
Qualifications
Why Join Us?
At Olink, Thermo Fisher Scientific, you will be part of a nurturing team that values integrity, innovation, and involvement. We offer an encouraging environment where your diverse experiences and perspectives are appreciated, enabling you to thrive and excel in your career. Come aboard and contribute significantly to global health and safety!
If you believe you’re the right fit for this role, we encourage you to submit your resume along with a cover letter highlighting your relevant experience. The last day for applications is on the 27th of March.